We are thrilled to announce that Tessl has successfully raised $125 million in our latest funding round, a significant milestone that underscores the demand for our innovative video and motion graphics solutions tailored specifically for the healthcare and pharmaceutical industries. At Tessl, we pride ourselves on transforming complex medical information into engaging visual narratives, enabling our clients to communicate intricate concepts with clarity and impact. This funding will allow us to enhance our product offerings, invest in cutting-edge technology, and expand our talented team of creatives and strategists. As the healthcare landscape evolves with new challenges and opportunities, our mission to boost audience understanding and engagement is more critical than ever. By leveraging this investment, we are poised to further refine our ability to deliver compelling visual storytelling that empowers professionals to effectively communicate vital health information. This infusion of capital will not only accelerate our growth trajectory but also enable us to forge strategic partnerships and explore new market opportunities. As we look to the future, our commitment to delivering high-quality, impactful visual solutions for the healthcare sector remains unwavering, and we are excited about the potential this funding unlocks as we continue to lead the charge in transforming how medical information is presented and perceived. Thank you to our investors who share our vision and confidence in the transformative power of visual communication in the healthcare field. Together, we are ready to make a lasting impact.





